Chembio Diagnostics (Chembio Diagnostics) EV-to-EBIT : -1.01 (As of May. 11, 2024)

Chembio Diagnostics EV-to-EBIT Chart

Chembio Diagnostics Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
EV-to-EBIT		Get a 7-Day Free Trial					-11.12	-6.61	-4.24	-1.31	-0.73

Chembio Diagnostics Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
EV-to-EBIT	Get a 7-Day Free Trial															-1.31	-0.87	-0.81	-0.61	-0.73

Competitive Comparison of Chembio Diagnostics's EV-to-EBIT

For the Diagnostics & Research subindustry, Chembio Diagnostics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chembio Diagnostics's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Chembio Diagnostics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Chembio Diagnostics's EV-to-EBIT falls into.

Chembio Diagnostics EV-to-EBIT Calculation

Chembio Diagnostics's EV-to-EBIT for today is calculated as:

Chembio Diagnostics's current Enterprise Value is $23.61 Mil.
Chembio Diagnostics's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chembio Diagnostics  (NAS:CEMI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Chembio Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

Chembio Diagnostics's Enterprise Value for the quarter that ended in Dec. 2022 was $14.97 Mil.
Chembio Diagnostics's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chembio Diagnostics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Chembio Diagnostics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Chembio Diagnostics (Chembio Diagnostics) Business Description